Amneal Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2018 to Q2 2024.
  • Amneal Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 319M shares, a 106% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 176M shares, a 16.7% increase from 2022.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 151M shares, a 0.58% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 152M shares, a 1.95% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 319M +164M +106% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 307M +155M +102% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 176M +25.2M +16.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 160M +8.3M +5.48% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 155M +3.89M +2.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 152M +2.22M +1.48% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 151M -877K -0.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 151M +2.1M +1.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 151M -993K -0.65% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 150M -1.33M -0.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 152M +2.91M +1.95% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 149M +1.73M +1.17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 152M +4.59M +3.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 151M +3.26M +2.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 149M +16.8M +12.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-03
Q3 2020 148M +16.8M +12.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 147M +19.4M +15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 148M +20.3M +15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 132M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 131M +2.51M +1.96% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 128M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 128M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 128M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.